1887

Journal of General Virology header logo

Volume 74, Issue 7

Neutralizing human monoclonal antibodies against Puumala virus, causative agent of nephropathia epidemica: a novel method using antigen-coated magnetic beads for specific B cell isolation Free

Abstract

Human monoclonal antibodies (MAbs) against Puumala (PUU) virus were generated and characterized. Human spleen B lymphocytes were preselected for specific surface immunoglobulin (Ig) using magnetic beads coated with the viral glycoproteins, and subsequently immortalized by Epstein—Barr virus transformation. Four IgG-positive monoclonal lymphoblastoid cell lines (LCLs) were established and have remained stable MAb secretors for over 12 months. Analyses of the antigen and epitope specificities recognized by the MAbs showed overlapping binding patterns of four antiglycoprotein 2-specific clones. Identical isotypes (IgGl λ) and isoelectric points (9·2) of the four MAbs suggested that they were derived from the same original clone. The MAbs reacted with eight PUU virus-like strains, but were negative for Hantaan, Seoul, and Prospect Hill viruses in an immunofluorescence assay, indicating binding to a conserved epitope unique for strains associated with the European form of haemorrhagic fever with renal syndrome, nephropathia epidemica. The MAbs neutralized all investigated PUU virus-like strains in a focus reduction neutralization test. The MAb neutralizing activity was significantly enhanced in the presence of human or guinea-pig complement. To stabilize and increase antibody secretion and to reduce the demand for culture medium supplements (e.g. fetal calf serum), three of the monoclonal LCLs were fused with the non-secreting human × mouse partner SPAM-8. Several of the established human × (human × mouse) monoclonal triomas grew faster and produced larger amounts of MAbs when compared with the original LCLs.

  • Received:
  • Accepted:
  • Published Online:
© Journal of General Virology 1993
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-7-1303
1993-07-01
2024-04-27
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/7/JV0740071303.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-7-1303&mimeType=html&fmt=ahah

References

  1. Baek LJ, Yanagihara R, Gibbs CJ, Jr, Miyazaki M, Gajdusek DC. 1988; Leakey virus: a new hantavirus isolated from Mus musculus in the United States.. Journal of General Virology 69:3129–3132
     [Google Scholar]
  2. Borrebaeck CAK. 1989; Strategy for the production of human monoclonal antibodies using in vitro activated B cells.. Journal of Immunological Methods 123:157–165
     [Google Scholar]
  3. Brummer-Korvenkontio M, Vaheri A, Hovi T, von Bonsdorff CH, Vuorimies J, Manni T, Penttinen K, Oker-Blom N, Lahdevirta J. 1980; Nephropathia epidemica. Detection of antigen in bank voles and serological diagnosis of human infection.. Journal of Infectious Diseases 141:131–134
     [Google Scholar]
  4. Chatenoud L. 1986; The immune response against therapeutic monoclonal antibodies.. Immunology Today 7:367–368
     [Google Scholar]
  5. Elliott RM. 1990; Molecular biology of the Bunyaviridae.. Journal of General Virology 71:501–522
     [Google Scholar]
  6. Goding JW. 1980; Antibody production of hybridomas. Journal of Immunological Methods. 39:285–308
     [Google Scholar]
  7. Gustaffson B, Jondal M, Sundqvist VA. 1991; SPAM-8, a mouse-human heteromyeloma fusion partner in production of human monoclonal antibodies.. Establishment of a human monoclonal antibody against cytomegalovirus. Human Antibodies and Hybridomas 2:26–32
     [Google Scholar]
  8. Harlow E, Lane D. 1988 Antibodies: A Laboratory Manual, 1st edn.Edited by Fraenkel-Conrat H, Wagner RR. New York: Cold Spring Harbor Laboratory;
     [Google Scholar]
  9. Horling J, Lundkvist A, Niklasson B. 1992; Antibodies to Puumala virus in humans determined by neutralization test.. Journal of Virological Methods 39:139–147
     [Google Scholar]
  10. Huggins JW, Hsiang CH, Cosgriff TM, Guang MY, Smith JI, Wu ZO, LeDuc JW, Zheng ZM, Meegan JM, Wang QN, Oland DD, Gui XE, Gibbs PH, Yuan GH, Zhang ZM, Meegan JM, Wang QN, Oland DD, Gui XE, Gibbs PH, Yuan GH, Zhang JM. 1991; Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome.. Journal of Infectious Diseases 164:1119–1127
     [Google Scholar]
  11. James K, Bell GT. 1987; Human monoclonal antibody production, current status and future prospects.. Journal of Immunological Methods 100:5–40
     [Google Scholar]
  12. Kozbor D, Lagarde AE, Roder JC. 1982; Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines.. Proceedings of the National Academy of Sciences, U.S.A. 79:6651–6655
     [Google Scholar]
  13. Lahdevirta J. 1971; Nephropathia epidemica in Finland. A clinical, histological and epidemiological study.. Annals of Clinical Research 3, supplement 8:1–154
     [Google Scholar]
  14. Lee HW, Lee PW, Johnson KM. 1978; Isolation of the etiologic agent of Korean hemorrhagic fever.. Journal of Infectious Diseases 137:298–308
     [Google Scholar]
  15. Lee HW, Baek LJ, Johnson KM. 1982; Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats.. Journal of Infectious Diseases 146:638–644
     [Google Scholar]
  16. Lee PW, Amyx HL, Gajdusek DC, Yanagihara RT, Goldgaber D, Gibbs CJ. 1982; New haemorrhagic fever with renal syndrome-related virus in indigenous wild rodents in the United States.. Lancet 1405:
     [Google Scholar]
  17. Lee PW, Gibbs CJ, Gajdusek D, Yanagihara R. 1985; Serotypic classification of hantaviruses by indirect immuno-fluorescent antibody and plaque reduction neutralization tests.. Journal of Clinical Microbiology 22:940–944
     [Google Scholar]
  18. Lum LG, Burns E, Janson MM, Martin PJ, Giddings BR, Seigneuret MC, Noges JE, Galoforo SC. 1990; IgG anti-tetanus toxoid antibody synthesis by human bone marrow. I. Two different distinct populations of marrow B cells and functional differences between marrow and peripheral blood B cells.. Journal of Clinical Immunology 10:255–264
     [Google Scholar]
  19. Lundkvist A, Niklasson B. 1992; Bank vole monoclonal antibodies against Puumala virus envelope glycoproteins; identification of epitopes involved in neutralization.. Archives of Virology 126:93–105
     [Google Scholar]
  20. Lundkvist A, Fatouros A, Niklasson B. 1991; Antigenic variation of European haemorrhagic fever with renal syndrome virus strains characterized using bank vole monoclonal antibodies.. Journal of General Virology 72:2097–2103
     [Google Scholar]
  21. Lundkvist A, Horling J, Niklasson B. 1993; The humoral response to Puumala virus infection (nephropathia epidemica) investigated by virus structural protein specific immunoassays.. Archives of Virology 130:121–130
     [Google Scholar]
  22. Miller G, Lipman M. 1973; Release of infectious Epstein-Barr virus by transformed marmoset leucocytes.. Proceedings of the National Academy of Sciences, U.S.A. 70:190–194
     [Google Scholar]
  23. Niklasson B, LeDuc J. 1984; Isolation of the nephropathia epidemica agent in Sweden.. Lancet1012–1013
     [Google Scholar]
  24. Niklasson B, LeDuc J. 1987; Epidemiology of nephropathia epidemica in Sweden.. Journal of Infectious Diseases 155:269–276
     [Google Scholar]
  25. Niklasson B, Jonsson M, Lundkvist A, Horling J, Tkachenko EA. 1991; Comparison of European isolates of viruses causing hemorrhagic fever with renal syndrome by a neutralization test.. American Journal of Tropical Medicine and Hygiene 45:660–665
     [Google Scholar]
  26. Niklasson B, Hornfeldt B, Mullart M, Settergren B, Tkachenko E, Myasnikov YA, Ryltceva EV, Leschin-skaya E, Malkin A, Dzagurova E. 1993; An epidemiological study of hemorrhagic fever with renal syndrome in Bashkirtostan (Russia) and Sweden.. American Journal of Tropical Medicine and Hygiene (in press).
     [Google Scholar]
  27. Ossendorp FA, Bruning PF, Van den Brink JAM, De Boer M. 1989; Efficient selection of high-affinity B cell hybridomas using antigen-coated magnetic beads.. Journal of Immunological Methods 120:191–200
     [Google Scholar]
  28. Rosen A, Britton S, Gergely P, Jondal M, Klein G. 1977; Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro.. Nature, London 267:52–54
     [Google Scholar]
  29. Rosen A. 1980; Agarose isoelectric focusing of monoclonal IgM and IgG antibodies. In Electrophoresis 79 p. 105–116Edited by Radola B. Berlin: Walter de Gruyter;
     [Google Scholar]
  30. Rosen A, Persson K, Klein G. 1983; Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells.. Journal of Immunology 139:2899–2902
     [Google Scholar]
  31. Schmaljohn CS, Hasty SE, Dalrymple JM, Leduc JW, Lee HW, Von Bonsdorff CH, Brummer-Korvenkontio M, Vaheri A, Tsai TF, Regnery HL, Goldgaber D, Lee PW. 1985; Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome.. Science 227:1041–1044
     [Google Scholar]
  32. Settergren B, Leschinskaya E, Zagidullin I, Fazlyeva R, Khunafina D, Niklasson B. 1991; Hemorrhagic fever with renal syndrome: comparison of clinical course in Sweden and in the western Soviet Union.. Scandinavian Journal of Infectious Diseases 23:549–552
     [Google Scholar]
  33. Sheshberadaran H, Niklasson B, Tkachenko EA. 1988; Antigenic relationship between hantaviruses analysed by immuno-precipitation.. Journal of General Virology 69:2645–2651
     [Google Scholar]
  34. Steinitz M, Klein G, Koskimies S, Makela O. 1977; Epstein-Barr virus induced B lymphocyte cell lines producing specific antibody.. Nature, London 269:420–422
     [Google Scholar]
  35. Tkachenko EA, Bashkirtsev VN, Van der Groen G, Dzagurova TK, Ivanov AP, Ryltseva EV. 1984; Isolation in Vero E6 cells of hantavirus from Clethrionomys glareolus captured in the Bashkiria area of the USSR.. Annales de la Societe beige de medicine tropicale 65:121–135
     [Google Scholar]
  36. Van der Groen G, Beelaert G, Hoofd G, Leirs H, Verhagen R, Yamanishi H, Tkachenko EA, Ivanov AP. 1987; Partial characterization of a hantavirus isolated from Clethrionomys glareolus captured in Belgium.. Acta virologica 31:180–184
     [Google Scholar]
  37. Yanagihara R, Gajdusek DC. 1988; Hemorrhagic fever with renal syndrome: a historical perspective and review of recent advances.. In CRC Handbook on Viral and Rickettsial Hemorrhagic Fevers pp 151–188Edited by Gear JHS. Boca Raton: CRC Press;
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-7-1303
Loading
Neutralizing human monoclonal antibodies against Puumala virus, causative agent of nephropathia epidemica: a novel method using antigen-coated magnetic beads for specific B cell isolation
J. Gen. Virol. 74, 1303 (1993); https://doi.org/10.1099/0022-1317-74-7-1303
/content/journal/jgv/10.1099/0022-1317-74-7-1303
/content/journal/jgv/10.1099/0022-1317-74-7-1303
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error